Sign In
Buy GS
$1,038.68
-53.93 (-4.94%)
At Close: Jun 05, 2026
Bank earnings: Key takeaways and analysis of Q3 results
05:31pm, Wednesday, 15'th Oct 2025
The economy is uncertain, but banks still managed strong earnings in Q3. We speak with experts to dissect the reports.
Goldman Sachs launches AI-driven overhaul after strong Q3, says Jefferies
03:02pm, Wednesday, 15'th Oct 2025
Goldman Sachs Group Inc (NYSE:GS, ETR:GOS) is entering a new phase of operational transformation dubbed “OneGS 3.0,” focused on artificial intelligence and centralized efficiency, following what J
JPMorgan, Goldman Sachs stay in China but businesses shift
02:35pm, Wednesday, 15'th Oct 2025
JPMorgan Chase and Goldman Sachs are sticking with their businesses in China as escalating tensions with the U.S. loom over global markets, bank executives said on Wednesday.
Goldman Sachs Acquires $7 Billion VC Platform Industry Ventures
02:13pm, Wednesday, 15'th Oct 2025
Goldman Sachs is acquiring Industry Ventures, a venture capital platform managing $7 billion.
These Analysts Revise Their Forecasts On Goldman Sachs After Better-Than-Expected Q3 Results
01:54pm, Wednesday, 15'th Oct 2025
Goldman Sachs Group Inc. (NYSE:GS) reported better-than-expected third-quarter results on Tuesday.
Goldman Sachs launches AI-driven overhaul after strong Q3, says Jefferies
11:01am, Wednesday, 15'th Oct 2025
Goldman Sachs Group Inc (NYSE:GS, ETR:GOS) is entering a new phase of operational transformation dubbed “OneGS 3.0,” focused on artificial intelligence and...
Gil Mandelzis, CEO & Founder of Capitolis, Honored by Goldman Sachs for Entrepreneurship
08:30am, Wednesday, 15'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Today, Goldman Sachs (NYSE:GS) is recognizing Gil Mandelzis as one of the Most Exceptional Entrepreneurs of 2025 at its Builders and Innovators Summit in Healdsburg, Califor
BOSTON--(BUSINESS WIRE)-- #Biotech--Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that Goldman Sac
Koya Medical Honored by Goldman Sachs for Entrepreneurship
08:00am, Wednesday, 15'th Oct 2025
Koya Medical CEO Andy Doraiswamy Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit DALLAS , Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recognizing K
Function Health Honored by Goldman Sachs for Entrepreneurship
08:00am, Wednesday, 15'th Oct 2025
Jonathan Swerdlin, Co-Founder & CEO, Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit NEW YORK , Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recogni
Top 4 Stocks As Bank Earnings Heat Up
05:00am, Wednesday, 15'th Oct 2025
JPMorgan, Wells Fargo, Goldman Sachs, and BlackRock kicked off earnings season with mixed but promising results for the financials sector. Collectively, their results offer a constructive setup for fi
JPMorgan CEO Jamie Dimon Says There's a 'Heightened Degree of Uncertainty'
08:34pm, Tuesday, 14'th Oct 2025
JPMorgan Chase CEO says the economy has been fairly resilient, but a number of factors like tariffs and geopolitical tensions are amplifying uncertainty.
BlackRock & Goldman Sachs Beat Q3 Expectations and Post Record AUM
08:21pm, Tuesday, 14'th Oct 2025
BlackRock and Goldman Sachs helped highlight Tuesday's earnings lineup after exceeding their Q3 expectations and hitting records in assets under management (AUM).
Goldman Sachs Makes AI the Centerpiece of Q3 Earnings
04:51pm, Tuesday, 14'th Oct 2025
Now even earnings numbers are taking a back seat to artificial intelligence (AI). In a dramatic turn of events Tuesday (Oct. 14), Goldman Sachs used its third‑quarter earnings announcement to unveil
Focused on how wealth clients can access alternative investments, says Goldman's Kristin Olsen
04:13pm, Tuesday, 14'th Oct 2025
Kristin Olsen, Goldman Sachs head of alternatives for wealth, joins 'Closing Bell' to discuss where Goldman sees the alternative asset category going, why the company's focusing on this asset class an
